前列腺癌局灶激光消融的系统综述与荟萃分析
该系统综述与荟萃分析纳入12项研究、421例接受局灶激光消融(FLA)的局限性前列腺癌患者,评估肿瘤学控制与功能结局。FLA后活检临床显著癌复发率为15%(95%CI 11-20%),术后12个月PSA平均降低2.3 ng/mL(95%CI 1.5-3.2 ng/mL)。性功能有统计学显著但非临床显著的下降(P<0.001,Cohen's d=0.29),排尿功能无统计学显著变化。
要点
- FLA后活检临床显著癌复发率为15%(95%CI 11-20%)。
- 术后12个月PSA平均降低2.3 ng/mL(95%CI 1.5-3.2 ng/mL)。
- 性功能下降有统计学意义但非临床显著,排尿功能无显著变化。
核心结论
- FLA提供的肿瘤学控制与其他局灶治疗相当,同时保留功能结局。
- 高质量对比研究有限,需进一步稳健研究验证这些发现。
研究设计与样本
- 系统综述与荟萃分析,按照PRISMA指南进行。
- 电子检索共纳入12项研究,包括421例接受FLA的局限性前列腺癌患者。
主要发现
- FLA后活检临床显著癌复发率为15%(95%CI 11-20%)。
- FLA后12个月PSA平均降低2.3 ng/mL(95%CI 1.5-3.2 ng/mL)。
- 性功能下降有统计学显著性(P<0.001)但非临床显著(Cohen's d=0.29)。
- 排尿功能在FLA后无统计学显著变化。
临床怎么用
- FLA可作为局限性前列腺癌的局灶治疗选择之一,肿瘤学控制与其他局灶治疗相当。
- 需关注性功能可能出现统计学显著但非临床显著的下降,排尿功能影响不显著。
局限性
- 患者选择、随访方案和复发定义存在异质性,限制跨研究比较与普适性。
- 高质量对比研究有限,需进一步稳健研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the oncological control and functional outcomes of focal laser ablation (FLA) in the management of localised prostate cancer. METHODS: A systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. An electronic search identified studies reporting outcomes of FLA for localised prostate cancer. The primary outcome was oncological control, assessed by recurrence on follow-up biopsy and prostate-specific antigen (PSA) level reduction. Secondary outcomes included adverse events and functional outcomes, specifically sexual and urinary function. RESULTS: The search identified 12 studies for inclusion, including 421 patients who underwent FLA for localised prostate cancer. The rate of recurrence of clinically significant cancer on biopsy following FLA was 15% (95% confidence interval [CI] 11-20%). The mean reduction in PSA level at 12-months post-FLA was 2.3 ng/mL (95% CI 1.5-3.2 ng/mL). There was a statistically significant (P < 0.001), but not clinically significant (Cohen's d = 0.29) decrease in sexual function, and no statistically significant change in urinary function following FLA. Heterogeneity in patient selection, follow-up protocols, and definitions of recurrence limit cross-study comparisons and generalisability. CONCLUSIONS: The present systematic review and meta-analysis found that FLA provides oncological control comparable to other focal therapies while preserving functional outcomes. However, the limited availability of high-quality comparative studies highlights the need for further robust studies to validate these findings.
引用
- Bushati Y, Guo AA, Muston BT, et al. Focal laser ablation in prostate cancer: a systematic review and meta-analysis. BJU Int. 2025. PMID: 41188055. doi:10.1111/bju.70064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。